Cited by 125Cancer Cells and Metastasis3D Printing in Biomedical ResearchMathematical Biology Tumor Growth

Impact of the spheroid model complexity on drug response

Open access
Hoffmann, Oliver Ingo, Ilmberger, Christian, Magosch, Stefanie, Joka, Mareile, Jauch, Karl-Walter, Mayer, Barbara·2015·Journal of Biotechnology

Abstract

Pharmaceutical investigators are searching for preclinical models closely resembling the original cancer and predicting clinical outcome. This study compares drug response of three in vitro 3D-drug screening models with different complexity. Tumor cell line spheroids were generated from the cell lines Caco-2, DLD-1, COLO 205, HT-29 and HCT-116, and treated with clinically relevant combination therapies, namely 5-FU/oxaliplatin (FO), 5-FU/irinotecan (FI) and the molecular drugs Cetuximab, Trastuzumab, Vorinostat and Everolimus. Treatment results were compared with spheroids originated from tumor cell lines (Caco-2, DLD-1) co-cultured with stromal cells (PBMCs, cancer-associated fibroblasts of colorectal origin) and spheroids directly prepared from colon cancer tissues. Different microenvironment compositions altered the tumor cell line spheroid response patterns. Adding PBMCs increased resistance to FO treatment by 10-15% in Caco-2 and DLD-1 spheroids but decreased resistance to FI by 16% in DLD-1 spheroids. Fibroblast co-cultures decreased resistance to FI in Caco-2 spheroids by 38% but had no impact on FO. Treatment of colon cancer tissue spheroids revealed three distinct response pattern subgroups not detectable in 3D cell lines models. The cancer tissue spheroid model mimics both tumor characteristics and the stromal microenvironment and therefore is an invaluable screening model for pharmaceutical drug development.

Integrity signals

Registry

Crossref · 10.1016/j.jbiotec.2015.02.029

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Hoffmann, O. I., Ilmberger, C., Magosch, S., Joka, M., Jauch, K.-W., & Mayer, B.
Affiliations
Ludwig-Maximilians-Universität München (DE)
Corresponding author
Mayer, Barbara
Venue
Journal of Biotechnology
Publisher
Elsevier BV
Published
2015-07
Volume
205
Pages
14-23
ISSN
0168-1656 (ISSN-L)
OpenAlex
W2057853951
Cited by
125
References
4
Citations by year
2026: 1 · 2025: 8 · 2024: 7 · 2023: 8 · 2022: 17 · 2021: 12 · 2020: 21 · 2019: 17 · 2018: 12 · 2017: 8 · 2016: 10 · 2015: 4
FWCI
4.95
Type
journal article
Language
en
Open access
Locations
  • Journal of Biotechnology (publishedVersion, cc-by-nc-nd)
  • PubMed (publishedVersion)
Funders
Bundesministerium für Bildung und Forschung
Topics
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
  • Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
Keywords
tumor spheroids, 3D cell culture models, colorectal cancer, drug response, combination chemotherapy, 5-fluorouracil, oxaliplatin, irinotecan, cetuximab, trastuzumab, vorinostat, everolimus, cancer-associated fibroblasts, peripheral blood mononuclear cells, tumor microenvironment, drug resistance, Caco-2 cells, DLD-1 cells, HCT116 cells, HT-29 cells, COLO 205
MeSH terms
Everolimus, Cetuximab, Trastuzumab, Irinotecan, Oxaliplatin, Vorinostat, Antineoplastic Agents, Antineoplastic Combined Chemotherapy Protocols, Camptothecin, Cell Survival, Cells, Cultured, Fluorouracil, Humans, Hydroxamic Acids, Organoplatinum Compounds, Tumor Cells, Cultured, Treatment Outcome, Stromal Cells, Spheroids, Cellular, Coculture Techniques, Caco-2 Cells, HT29 Cells, HCT116 Cells, Cell Line, Tumor, Tumor Microenvironment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review